Zobrazeno 1 - 10
of 81
pro vyhledávání: '"Sandra Zhang"'
Based on recent advanced diffusion models, Text-to-image (T2I) generation models have demonstrated their capabilities in generating diverse and high-quality images. However, leveraging their potential for real-world content creation, particularly in
Externí odkaz:
http://arxiv.org/abs/2409.00313
Autor:
Ikuo Hirano, Marc E. Rothenberg, Sandra Zhang, Claudia de Oliveira, Christina M. Charriez, Karin S. Coyne, Elizabeth Dansie Bacci, Evan S. Dellon
Publikováno v:
American Journal of Gastroenterology. 118:744-747
Autor:
Inge De Lepeleire, Randolph P. Matthews, Dirk Schürmann, Deanne J. Rudd, Vanessa Levine, Sabrina Fox-Bosetti, Sandra Zhang, Martine Robberechts, Andreas Hüser, DariaJ Hazuda, JayA Grobler, Aubrey Stoch, Marian Iwamoto
Publikováno v:
Journal of Virus Eradication, Vol 3, Iss , Pp 2- (2017)
Externí odkaz:
https://doaj.org/article/6c4df87c6b224d3eaa78329f23363c77
Publikováno v:
Fair Disclosure Wire (Quarterly Earnings Reports). 05/23/2024.
Autor:
Martine Robberechts, Evan J. Friedman, Dirk Schürmann, Deanne Jackson Rudd, Inge De Lepeleire, Sabrina Fox-Bosetti, Sandra Zhang, Andreas Huser, Daria Hazuda, Marian Iwamoto, JayA Grobler
Publikováno v:
Journal of Virus Eradication, Vol 2, Iss , Pp 4- (2016)
Externí odkaz:
https://doaj.org/article/60ce5e9153db433f920ef25e975011ea
Autor:
Ikuo Hirano, Marc Rothenberg, Sandra Zhang, Cristian Rodriguez, Christina Charriez, Karin Coyne, Evan Dellon
Publikováno v:
Journal of Allergy and Clinical Immunology. 149:AB69
Publikováno v:
Fair Disclosure Wire (Quarterly Earnings Reports). 05/19/2020.
Autor:
Ulhas P. Naik, Srikanth Nagalla, Matt S. Anderson, Jocelyn Gilmartin, Brittany Walker, Walter K. Kraft, Sandra Zhang, Ferdous Gheyas, Derek L Chappell, Jay Horrow, Rebecca E Wrishko
Publikováno v:
Clinical and Translational Science
The effect of the protease-activated receptor-1 (PAR-1) antagonist vorapaxar on human bleeding time is not known. This was a randomized, two-period, open-label trial in healthy men (n = 31) and women (n = 5). In period 1, subjects received 81 mg aspi
Publikováno v:
Fair Disclosure Wire (Quarterly Earnings Reports). 03/01/2023.
Autor:
Deanne Jackson Rudd, Sabrina Fox-Bosetti, Aubrey Stoch, Vanessa Levine, Kerry L. Fillgrove, Marian Iwamoto, Randolph P. Matthews, Charles Tomek, Sandra Zhang
Publikováno v:
Open Forum Infectious Diseases
Background MK-8591 is a novel, highly potent, nucleoside reverse transcriptase translocation inhibitor (NRTTI) that is in development for the treatment of HIV-1 infection. MK-8591 is not expected to be a perpetrator or victim of drug–drug interacti